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ABSTRACT:
Autosomal dominant leukodystrophy
(ADLD) is an adult onset demyelinating disorder that is
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caused by duplications of the lamin B1 (LMNB1) gene.
However, as only a few cases have been analyzed in
detail, the mechanisms underlying LMNB1 duplications
are unclear. We report the detailed molecular analysis
of the largest collection of ADLD families studied, to
date. We have identified the minimal duplicated region
necessary for the disease, defined all the duplication
junctions at the nucleotide level and identified the first
inverted LMNB1 duplication. We have demonstrated that
the duplications are not recurrent; patients with identical
duplications share the same haplotype, likely inherited
from a common founder and that the duplications originated from intrachromosomal events. The duplication
junction sequences indicated that nonhomologous end
joining or replication-based mechanisms such fork stalling
and template switching or microhomology-mediated break
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induced repair are likely to be involved. LMNB1 expression was increased in patients’ fibroblasts both at mRNA
and protein levels and the three LMNB1 alleles in ADLD
patients show equal expression, suggesting that regulatory
regions are maintained within the rearranged segment.
These results have allowed us to elucidate duplication
mechanisms and provide insights into allele-specific
LMNB1 expression levels.
Hum Mutat 34:1160–1171, 2013. Published 2013 Wiley Periodicals, Inc.∗
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Introduction
Adult-onset autosomal dominant leukodystrophy (ADLD) is a
rare demyelinating disease with an onset in the fourth or fifth decade
of life. The clinical presentation usually consists of initial autonomic
symptoms followed by pyramidal signs and ataxia [Lin et al., 2011;
Padiath and Fu, 2010]. Cardiovascular and skin noradrenergic failure was recently found in one ADLD family, and might be another
hallmark of the disease [Guaraldi et al., 2011]. Magnetic resonance
imaging showed diffuse and symmetrical supra- and infratentorial white matter changes, particularly of cerebellum, corticospinal
tracts, and corpus callosum. Some patients showed brain and spinal
cord atrophy [Sundblom et al., 2009]. Histological evaluation of
brain lesions displays astrogliosis and oligodendrocyte preservation
[Coffeen et al., 2000; Melberg et al., 2006].
ADLD was shown to be caused by a duplication involving the
lamin B1 gene (LMNB1; MIM #150340), on chr. 5q32. The duplication resulted in an increased expression of lamin B1 mRNA
and protein in patient brain tissue [Padiath et al., 2006]. ADLD
thus joins a growing list of neurological diseases caused by changes
in gene copy number. These include Pelizaeus–Merzbacher Disease
(PMD), caused by duplications of the proteolipid 1 protein (PLP1;
MIM #300401) and developmental delay with intellectual disability
caused by duplications of the methyl-CpG-binding protein 2 gene
(MECP2; MIM #300005) [Lee and Lupski, 2006; Stankiewicz and
Lupski, 2010].
After the initial identification of the LMNB1 duplication in three
independent ADLD families, sporadic reports of single ADLD families from different parts of the world were published [Brussino
et al., 2009a; 2009b; Dos Santos et al., 2012; Fogel et al., 2012; Meijer
et al., 2008; Padiath and Fu, 2010; Schuster et al., 2011]. However,
in all these reports, only approximate duplication boundaries were
determined.
Apart from the characterization of the duplication junction sequences in two patients in the initial report that identified LMNB1
duplications, no further LMNB1 duplication junctions have been
resolved at the base pair level [Padiath et al., 2006; Padiath and
Fu, 2010]. The analysis of duplication junction sequences is essential for understanding the molecular mechanisms that give rise to
such events. Nonallelic homologous recombination (NAHR) and
non homologous end joining (NHEJ) have been proposed for the
generation of both normal and pathogenic copy number variations [Hastings and Rosenberg, 2011; Stankiewicz and Lupski, 2010;
van Binsbergen, 2011; Woodward et al., 2005]. Replication-based
mechanisms such Fork stalling and template switching (FoSTeS)
and microhomology-mediated break induced repair (MMBIR) have

also been implicated [Hastings et al., 2009; Stankiewicz and Lupski,
2010].
In this report, we describe, to the best of our knowledge, the
analysis and systematic molecular characterization of the largest
collection of ADLD patients with LMNB1 duplications presently
available.

Methods
Patients
DNA samples were obtained from 31 ADLD patients from 20
independent families from different laboratories worldwide (USA
n = 8, Italy n = 5, Sweden n = 4, Germany n = 4, France n = 3,
India n = 3, Canada n = 2, Israel n = 1, Brazil n = 1). Nine of the
20 families have been described previously (Supp. Table S1). The
remaining families were screened at the A.I. duPont Hospital for
Children, University of Torino, UCLA, Children’s National Medical
Center and the University of Pittsburgh. All studies were carried out
after obtaining ethical approval from the institutional review boards
of the respective institutions. DNA was extracted from blood or cell
lines using the Puregene DNA isolation kit or the Qiamp blood kit
(Qiagen, Mannheim, Germany). All families were screened based on
clinical symptoms consistent with the ADLD phenotype. Fibroblast
cell lines were available for six patients (IT1, IT2, IT3, A2, A3, BR1).
PAXgene-stabilized blood sample for RNA isolation (Qiagen) was
obtained from one patient (IT3–1).

Custom Array Comparative Genomic Hybridization
and Breakpoint Identification
To define the boundaries of the duplications, two custom
8 × 15K array Comparative Genomic Hybridization (aCGH) assays were designed using the eArray tool (https://earray.chem
.agilent.com/earray/, Agilent Technologies Inc., Palo Alto, CA). Array CGH assays carried out at the University of Torino had an average
probe spacing of ∼800 bp between 125,010,000 and 127,269,000 Mb
on chromosome 5. Arrays at the University of Pittsburgh had an average probe spacing of ∼200 bp between positions chr5:125,112,315
and chr5:127,172,712. Experiments were performed following manufacturer’s instructions and the slides scanned on either a G2565BA
or G2565CA scanner and analyzed using Agilent CGH Analytics
software ver.5.0.14 or the Agilent Cytogenomics software 2.0.6.0
(Agilent Technologies Inc.). Duplication breakpoints were identified by PCR amplification with different combination of primers in
each patient (Supp. Table S2) using the KAPA2G Fast PCR kit (Kapa
Biosystems, Inc., Woburn, MA), or the New England Biolabs Long
PCR kit (NEB, Ipswich, MA) following manufacturer’s instructions.
Control samples were also used in the long PCR reactions to confirm
that amplification occurred only in patient samples.
Inverse PCR was performed on the genomic DNA derived from
the patient in BR1 family to identify duplication breakpoints using
a protocol described previously using either RsaI or BglII restriction
endonucleases (primers used are listed in Supp. Table S2).

Bioinformatics Analyses
All sequences and sequence coordinates were obtained from
the UCSC genome browser (assembly GRCh37/hg19) and are
from chromosome 5. For the majority of the analyses, we selected a 200 bp region surrounding the centromeric and telomeric
duplication breakpoint sequences (referred to as patient breakpoint
HUMAN MUTATION, Vol. 34, No. 8, 1160–1171, 2013
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sequences) and compared them with 500 sequences of 200 bp (referred to as control sequences) randomly selected from chromosome
5 using an approach similar to that described previously [Carvalho
et al., 2009; Vissers et al., 2009]. In the control sequences, the breakpoint was arbitrarily defined as sequence between base 100 and 101
(the middle of the sequence). We calculated the percentage of simulated breakpoints that fell within repetitive elements. For GC%
analysis, we used a 4 kb region surrounding the patient duplication
breakpoints and 500 4-kb random sequences from chromosome 5.
The following online tools were used to compare the patient
breakpoints and control sequences: RepeatMasker (http://www
.repeatmasker.org/), GEECEE (http://150.185.138.86/cgi-bin/
emboss/geecee), Fuzznuc (http://150.185.138.86/cgi-bin/emboss/
fuzznuc) [Vissers et al., 2009], MEME (http://meme.sdsc.edu/
meme/intro.html), and the database Non-B DB (http://nonb
.abcc.ncifcrf.gov /apps/site/default). Low copy repeats (LCRs) were
identified using the segmental duplication track on the UCSC
genome browser (http://www.genome.ucsc.edu).

Primer Extension Assay
To verify if one of the two LMNB1 alleles was preferentially expressed in duplication carriers, we evaluated the relative amount
of the two alleles of a heterozygous SNP (rs#1051644, c.∗ 239C>T)
in the 3 UTR of LMNB1 using a primer extension assay with the
SNaPshot System (Applied Biosystems, Foster City, CA).
Two reference plasmid clones, one for each rs#1051644 allele, were
prepared to build a reference curve. We amplified a 497 bp fragment
centered on the SNP with 500 nM primers 5 -aaagggtccatttgaggttagg
and 5 -tggtttatttaccctcccctcct from a heterozygous control.
The PCR product was gel purified with the HiYeldTM Gel/PCR
Fragments Extraction Kit (RBC Bioscience, Taipei, Taiwan), inserted
into a pTZ57R/T plasmid using the TA Cloning Kit (Invitrogen/Life
technologies, Grand Island, NY). They were sequence verified to
isolate one clone for each allele (pTZ57R/T LMNB1 c.∗ 239C and
pTZ57R/T LMNB1 c.∗ 239T) and quantified on a Qubit instrument
(Invitrogen/Life Technologies). Mixes were prepared with proportions of 35%, 50%, and 65% C/T alleles and used to obtain a standard
curve.
Primer extension was performed amplifying from genomic
DNA with the primers and conditions reported above. On
cDNA, we amplified a 394 bp fragment using primers 5 -gaa
gaacttttccaccagcag and 5 -tggtttatttaccctccctcct. PCR products were
purified using Exonuclease I and Shrimp Alkaline Phosphatase
(SAP, MBI-Fermentas, Vilnius, Lithuania) and the primer extension reaction performed with primers annealing immediately before and after the SNP base (5 -gactgactctgaacttaataactgtgtactgtt,
5 -ctgactgactgacttgaggaaccccttcc). SNaPshot reactions were purified
using Shrimp Alkaline Phosphatase (SAP), loaded on an ABI-Prism
3100 Avant capillary electrophoresis instrument with a GS120-Liz
marker and analyzed using the GeneScan ver 3.7 software (Applied
Biosystems).
Additional methods are available in the Supporting Information.
LMNB1 gene variants have been submitted to the Leiden Open
Variation Database (www.lovd.nl/LMNB1)

Results
Characterization of ADLD Duplications
We collected 20 independent ADLD families, in which genomic
LMNB1 duplication was initially identified by aCGH, QT-PCR or
Multiplex Ligation-dependent Probe Amplification (Table 1). Ap-
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proximate duplication boundaries have previously been described
in seven cases [Brussino et al., 2009a; Dos Santos et al., 2012; Meijer
et al., 2008; Schuster et al., 2011]. Using a custom array encompassing 2 Mb around the LMNB1 gene, we were able to accurately
determine all duplication sizes, finding a total of 16 unique rearrangements (Fig. 1A and B, Table 1). Three of the duplications were
shared by more than one family (Table 1): one was found in three
families (A6, A7, and K2–3) and the other two in two families each
(A8 and AV1, FR1 and FR2).
Duplication sizes ranged from ∼128 to ∼475 kb, which represent
the smallest and largest ADLD duplications so far identified. The
largest duplication, found in the patient from the BR1 family, also
included the PHAX, ALDH7A1, and GRAMD3 genes.
The centromeric breakpoint closest to LMNB1 was found in sample A14, and it was localized 9.8 kb upstream of the first exon of
the LMNB1 gene. The closest telomeric breakpoint to LMNB1 was
found in patient BR1, 1.8 kb downstream the last exon of LMNB1.
The boundaries of the rearrangements in these two samples mark
a ∼72 kb minimal critical duplicated region required for ADLD,
between chr5:126,102,443 and chr5:126,174,517 and includes the
LMNB1 gene only (Fig. 1A). In addition to the duplication, families A6, A7, and K2–3 also showed the presence of a triplication
of ∼13 kb, within the second intron of the MARCH3 gene (Fig. 1,
Supp. Fig. S1).

Characterization of Tandem Duplication
Junction Sequences
Duplication junction sequences were identified by long-range
PCR by attempting to amplify across the unique duplication junction T1–C2, using outward facing primers and assuming a direct tandem orientation of the duplicated segment (Fig. 1B, Supp.
Table S2). Healthy control samples were also used in the long-range
PCR reactions to confirm that amplification only occurred from
patient DNA (data not shown). Using this strategy, we were able to
generate patient-specific amplification products from 15 duplication junctions in addition to the triplication junction. In families
with multiple affected members, we confirmed that all affected individuals had identical duplications using the duplication junctionspecific PCR primers.
Sequencing these PCR products allowed us to resolve all the
15 duplication junctions at the nucleotide level (Fig. 2 and Table 1).
However, this technique did not allow identifying the breakpoints
of the duplication in family BR1 (Fig. 1), where the junction was
found to be more complex (described in detail in the next section).
Eleven of these 15 junctions showed short stretches of microhomology/overlap ranging from 1 to 6 nucleotides (Fig. 2 and
Table 1). Four of the junction sequences (families A1, IT3, A10,
FR1/FR2) showed the presence of an insertion of 4, 11, or 12 nucleotides. Interestingly, these duplications with insertions at their
junctions also showed a clustering of their centromeric breakpoints
within ∼25 kb (IT3, A10, and FR1/FR2 clustered within ∼8 kb) (Fig.
1A). Assuming a random distribution of breakpoints, this clustering
was found to be statistically significant (P = 7 × 10–3 ).
Patient A3, had an insertion of one nucleotide and a deletion of
the adjacent nucleotide, 3 bp from the duplication junction (Fig. 2).
All other junction sequences matched perfectly with the reference
sequence.
To identify the triplication junction in families A6, A7, and K2–3,
we assumed that this was the result of a head to tail tandem duplication on one of the duplicated alleles (Fig. 1C). Using primers
spanning this putative junction, we were able to obtain a PCR

Table 1. Details of the 16 Unique LMNB1 Duplications
Family #

Size

Centromeric
breakpoint

Telomeric
breakpoint

1

Al

277,929

126,023,423

126,301,352

2

A2

203,432

126,072,067

126,275,499

3

A3

189,731

126,078,035

126,267,766

4

A4

150,283

126,099,593

126,249,876

5

A5

238,946

126,018,887

126,257,833

6

A6, A7, K2-3

169,456

126,096,876

126,266,332

6∗

A6, A7, K2-3

13,656

126,230,827

126,244,483

7

A8, AV1

340,785

126,003,283

126,344,068

8

A10

203,842

126,041,308

126,245,150

9

All

228,672

126,022,573

126,251,245

10

A14

229,243

126,102,443

126,331,686

11

Gl

148,085

126,054,572

126,202,657

12

FR1,FR2

234,020

126,049,232

126,283,252

13

IT1

153,769

126,068,010

126,221,779

14

IT2

127,608

126,072,145

126,199,753

15

IT3

324,675

126,040,794

126,365,469

16

BR1

474,998

125,699,519

126,174,517

Nature of
junction

Repetitive element at duplication
breakpoints

Insertion of
“GCAC”
Microhomology of
“T”
Microhomology of
“AC”
19 bp Homology of
AluY element
Microhomology of
“AAGGGA”
Microhomology of
“CT”
146 bp Homology
of LINE element
Microhomology of
“AC”
Insertion of
CTAGTG
Microhomology of
“GG”
Microhomology of
GA
Microhomology of
“CAG”
Insertion of
TAGCTAAGTTA
Microhomology of
“AA”
Microhomology of
“GCTG”
Insertion of “ATG
TTTGTATTT”
Complex

Possible
mechanism

Centromeric

Telomeric

–

–

NHEJ

–

MER82

–

–

ALUY

ALUY

–

–

–

–

LIP A3

LIP A3

NHEJ/ FoSTeSMMBIR
NHEJ/ FoSTeSMMBIR
NAHR/ FoSTeSMMBIR
NHEJ/ FoSTeSMMBIR
NHEJ/ FoSTeSMMBIR
NAHR

LTR7B

–

LTR78B

LIP A3

–

–

ALUSg

L2c

–

–

L1MB7

L1MC1

NHEJ/ FoSTeSMMBIR
NHEJ/ FoSTeSMMBIR
NHEJ/ FoSTeSMMBIR
NHEJ

ALUSx

–

NHEJ/ FoSTeSMMBIR
NHEJ/ FoSTeSMMBIR
NHEJ

LIMB 7

–

FoSTeS-MMBIR

ALUSx
–

NHEJ/ FoSTeSMMBIR
NHEJ

∗

Note: Coordinates refer to chromosome 5, February 2009 assembly of the reference genome (GRCh37/hg19), Asterisk ( ) indicates triplication.

amplification product in the patient sample only, confirming the
initial hypothesis. The ends of the triplicated segment showed a
146 bp homology and were found to lie in two directly oriented
LIPA3 LINE elements of ∼6 kb in size that shared 96% sequence
identity (Fig. 2).

Characterization of an Inverted Duplication
In the duplication in family BR1, the strategy of using outward
primers to amplify across duplication junctions did not yield a
product. Using the junction coordinates determined by aCGH, we
used inverse PCR to identify the sequences flanking the centromeric
and telomeric duplication breakpoints. This revealed the presence of
complex duplication junction architectures (Fig. 3A). The C2 breakpoint corresponded to position chr5:125,699,519 on the reference
genome (all coordinates are for chr. 5). This was flanked by a segment
in the opposite orientation that began at position chr5:126,097,581
(breakpoint I2, Fig. 3A). Breakpoint I2 was located within an Alu
repeat, and the transition was marked by a “CCT” microhomology
sequence (Fig. 3A).
The T2 breakpoint corresponded to position 126,174,517 and
it was flanked by a sequence that began at position 126,097,260
in direct orientation (J2, Fig. 3A). The sequence transition was
marked by a “AGAA” microhomology. This segment continued for
78 bp into the breakpoint J1, and then transitioned to a different
segment beginning at position 126,096,808 (junction I1) in the op-

posite orientation. This junction was marked by a microhomology
of six base pairs (AGCCAC). The J1 and I1 breakpoints were located
within Alu Y repeats adjacent to each other (AluY-A and AluY-B)
with a sequence identity of 89% but in opposite orientations. The
J1 breakpoint was in the same AluY-B repeat as the I2 junction
(Fig. 3B).
This sequence configuration suggested that the entire duplicated
segment (C2–T2) corresponding to ∼475 kb had been inverted
and embedded between the breakpoints I1 and I2 (Fig. 3A). PCR
primers designed to amplify across these duplication junctions were
able yield a product in the patient sample but not in control samples from unaffected individuals. Previous reports have described
tandem duplications that have been linked by sequence fragments
that are in an inverted orientation leading to a duplication-inverted
triplication–duplication structure [Carvalho et al., 2011]. To determine if this was the case in our patient we reexamined the aCGH
plot in vicinity of the insertion sites, that is, between I1and I2
(Fig. 3B) but we did not observe probes signals with a log ratio
corresponding to a triplication. On the contrary, three probes with
signals corresponding to a copy number of one were surrounded by
probes with signals corresponding to a duplication (Fig. 3B). This
suggested that during the formation of the duplication, there has
been a loss of ∼500 bp from the interrupted segment (Fig. 3B).
Fluorescence in situ hybridization analysis (FISH) with probes
mapping on the middle and the end of the duplicated segment confirmed the presence of the inverted duplication (Fig. 3C). The given
hybridization pattern was observed in more than 70% of enlarged
HUMAN MUTATION, Vol. 34, No. 8, 1160–1171, 2013
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Figure 1. Overview of the genomic rearrangements in the ADLD families. A: Modified output from the UCSC genome browser showing the
LMNB1 gene duplications in 20 ADLD families (16 unique duplications) and their surrounding genomic region. The duplications are marked in blue,
with the exceptions of the BR1 duplication/inversion, which is in yellow and the triplicated segment, which is in green. Duplications marked with
asterisks (∗ ) have sequence insertions at their duplication junctions and show a clustering of their centromeric breakpoints within a 25 kb segment.
The minimal critical region duplicated in ADLD of ∼75 kb is also shown. The location of SINE repetitive elements and microsatellite markers
used in genotyping (modified UCSC genome browser tracks) are shown below. Note the enrichment of SINE elements (the majority of which are
Alu repetitive elements) centromeric to the LMNB1 gene. B: Schematic representation of the three LMNB1 duplication configurations identified.
C1–T1 and C2–T2 represent the duplicated segments that are derived from the parental genomic region, C–T. Black arrows represent orientation
of primers used to for PCR and sequencing across duplication and triplication junctions.

interphase nuclei. In the remaining cells, sufficient resolution could
not be achieved to allow us to identify any discernable structure.

Analysis of Genomic Architecture of Duplication
Breakpoints
We analyzed the genomic architecture of the centromeric and
telomeric breakpoints in the 16 independent duplications to determine if they played a role in the rearrangement process. The
triplication junction was not included in these analyses, as it
seemed to be the result of an event independent from the LMNB1
duplication.
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We did not identify any LCR (also known as segmental duplications) in the genomic region surrounding the LMNB1 gene within
100 kb of any of the duplication breakpoints.
Thirteen of the 32 analyzed breakpoints (41%) were within
repetitive sequences, as defined by the Repeat Masker software
(Fig. 2, Table 1). In four patients, both the proximal and distal
junctions were located in repetitive elements. Among these, the
duplication in family A4 had two AluY repeats sharing ∼90%
identity at both ends. In the remaining patients, no significant sequence identity was found between the centromeric and telomeric
breakpoints.
We did not find a significant enrichment of repetitive elements
at these breakpoints compared with 500 randomly selected control

Figure 2. LMNB1 duplication junction sequences. Nucleotide positions from chromosome 5 (GCRh37/hg19) are indicated on the left of each
junction. In each case, the reference sequence corresponding to the telomeric end of the duplication (red), the junction fragment present in LMNB1
duplication carriers (red and blue) and the reference sequence corresponding to the centromeric end the duplication (blue) are shown. The grey
highlighted sequences represent either the presence of microhomology or nucleotide insertions at the duplication junctions. In sample A3, a single
base pair deletion and an adjacent mismatch compared with the reference sequence were present. Repetitive elements present at the duplication
junctions are also displayed. At the triplication junction (A6, A7, K2–3) the dotted line represents the extended part of the 146 bp segments that
shows perfect homology.

sequences. However, considering Alu repetitive elements alone, we
found that four of the 16 (25%) centromeric breakpoint sequences
were within an Alu element (Fig. 4A) compared with 34 of 500
(7%) control sequence breakpoints (P = 0.02, Fisher’s exact test).
A similar result was observed when the 200-bp region surrounding
the breakpoints was compared with the control sequences (Fig. 4B).
No such difference was observed when telomeric breakpoints were
analyzed (Fig. 4B).
As an increased GC% has been associated with greater instability of duplications in the region of MECP2 [Bauters et al., 2008],
we sought to determine the GC content of the LMNB1 duplication breakpoints. The GC contents of the centromeric (44.5%) and
telomeric (41.8%) breakpoint sequences were significantly higher
when compared with control sequences (39.3%) (P = 1.6 × 10–8 for
centromeric and P = 0.005 for telomeric sequences, Student’s t-test)
(Fig. 4C).
Given the difference in the Alu repeat enrichment and GC content between the centromeric and telomeric breakpoints, we investigated whether this was the result of differences in the overall
composition of the genomic regions in which these breakpoints
were located. We arbitrarily chose a ∼600 kb region centered on
the LMNB1 gene. The centromeric half of this region revealed a

much higher Alu density (37.1%) compared with the telomeric
half (9.1%) or the whole chromosome 5 (8.4%) (Supp. Table S3).
Analysis of the GC content of this 600 kb region found that it
was 42% (43.1% for the centromeric half; 40.1% for the telomeric
half) compared with 39.2% for the whole chromosome 5 (Supp.
Table S3).

Analysis of Sequence Motifs at Breakpoints
None of the 40 sequence motifs previously reported to predispose
to DNA breakage [Vissers et al., 2009] were found to be statistically
overrepresented at patients’ breakpoints (Supp. Table S4).
Previous reports have suggested that the trinucleotide sequence
CTG/CAG is enriched in the vicinity of MECP2 and PLP1 duplication junction sequences [Carvalho et al., 2009]. We found an
increased frequency of the CTG/CAG motif at the telomeric breakpoints when compared with control sequences (P = 0.02, Student’s
t-test). We did not observe an enrichment of CCG/GGC motifs
(data not shown) suggesting that the enrichment of the CTG/CAG
motif was unlikely to be simply a result of differences in GC content
between patient and control sequences.
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Figure 3. Architecture of the BR1 inverted duplication. A: Schematic representation of the inverted duplication in BR1. The C1 and T1 junctions
represent the extents of the duplication. The duplicated segment C2–T2 (brown) is inverted and embedded between junctions I1 and I2 (red vertical
lines). Analysis of the junction sequences reveals that the I1–T2 junction is complex with a 78 bp J1–J2 segment (green) interspersed within
it. The J1–J2 and the T2–C2 segments are in the reverse orientation. The red and green circles mark the location of the BAC probes used for
FISH. Sequence alignments of the I1–J1, J2–T2, and C2–I2 junctions (center) are shown with their respective reference sequences (above and
below). In the sequence alignments the regions of microhomology are marked in black. The I1–J2 sequences fall within adjacent AluY repeats
which are in an opposite orientations (arrows). B: Overview of the genomic region containing breakpoints I1–I2 (red vertical lines) and J1–J2
(green vertical lines) on the reference genome. Arrows mark the orientation of the Alu elements. The array CGH plot below shows the location
of a nonduplicated segment (solid red horizontal bar) surrounded by a duplicated region in the BR1 sample. The y-axis represents relative probe
intensity values on a Log2 scale. C: FISH analysis using the fluorescent labeled BAC probes RP11–692P23 (red) and RP11–772E11 (green). The
red arrow points to the chromosome with the duplicated allele, whereas the white arrow shows the chromosome with the normal allele. The
presence of a red–green–green–red pattern confirms the presence of the inverted duplication. The normal chromosome shows a red–green pattern.
D: Model showing the replication fork switching that could give rise to the BR1 duplication. Relative locations of the duplication junctions are
marked together with the Alu repetitive elements and genes involved in the rearrangement. Arrowheads show direction of DNA relative to the
positive strand. Circled numbers represent FoSTeS events. Colored circles represent the duplicated genes.

1166

HUMAN MUTATION, Vol. 34, No. 8, 1160–1171, 2013

Figure 4. Bioinformatics analysis of duplication breakpoints and surrounding genomic regions. A: Analysis of repetitive elements at duplication
junctions. Light gray columns show all repetitive elements and dark gray columns show Alu repetitive elements only. An enrichment of Alu repetitive
elements in centromeric breakpoints was present. B: Analysis of repetitive elements in 200 bp sequences surrounding duplication breakpoints
in patients versus simulated breakpoints of control sequences. Only centromeric sequences show an enrichment of Alu repetitive elements.
C: GC% in 4 kb sequences surrounding duplication breakpoints in patients versus simulated breakpoints in controls. All breakpoint sequences show
significantly higher GC% than control sequences. D: Enrichment of CTG/CAG motifs in duplication breakpoint sequences. CTG/CAG motifs were
found to be significantly enriched in telomeric breakpoint sequences. In all panels asterisks (∗ ) represents a statistical significance of P < 0.05,
and double asterisks (∗∗ ) represents P < 0.001. E: Consensus sequence motif at centromeric duplication breakpoints. F: Consensus sequence motif
at telomeric duplication breakpoints. In both (E) and (F), x-axis represents position of the nucleotide in the motif and the height of the nucleotide
represents the probability of observing that particular nucleotide at that position. Both motifs were found to significantly overrepresented in the
respective patient breakpoint sequences when compared with control sequences (P < 10−6 ).

Using the MEME software, we searched for the presence
of novel motifs in the duplication breakpoint sequences. At
centromeric breakpoints we found the ‘GGVTKTYMHYVTGTTRVCCWKGVTSSTYKBGMWCWSBBRRCCWYRKK’ motif significantly enriched (five of the 16 breakpoints, P = 8.6 × 10–8 ,
Fisher’s exact test) (Fig. 4E). On further examination, we determined that this motif was part of Alu elements in four
of the five breakpoint sequences suggesting that the Alu elements were responsible for the motif. At telomeric breakpoints the motif “ASKRGCTSCAR” was significantly overrepresented (six of the 16 breakpoints, P = 8.5 × 10–9 , Fisher’s exact test) (Fig. 4F). We were unable to determine whether this sequence motif represented a known structural or functional DNA
element.

We found non B-DNA conformations (Z-DNA, cruciform, and
triplexes), known to be implicated in DNA rearrangements, only at
the telomeric breakpoint sequence of patient A10 (Z-DNA forming
sequence “CCGTACGTGTGCACAGGGGCATGG”).

Chromosomal Origin and Haplotype Analysis
of Duplications
To determine whether the duplications were the result of interor intrachromosomal rearrangements, we typed eight microsatellite
markers across the duplicated segment (Fig. 1A and Table 2). We did
not find triple alleles in any of the samples strongly suggesting that
the duplications resulted from intrachromosomal rearrangements.
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Table 2. Haplotype Analysis of ADLD Patients
S. No

1
2
3
4
5
6
7
8
9
10

Family ID

A1
A2
A3
A4
A6, A7, K2–3
A8, AV1
A11
FR1, FR2
IT1
IT3

Microsatellite marker alleles (bp)
Q1

Q2

Q4

Q5

Q6

Q7

Q10

Q8

337
337/345
345
343
349
347
347
353
345
335

211
221
263
223
227
253
255
237
253
203

199
191
191/193
195
193
193
197
193
191/193
195/197

480
480
492/506
483
492
492
477
498
492
492

186
200
194
200
172
198
202
200
200
184/194

248
250
248/250
250
248
250/252
250
248
254
256

238
266
238
266
238
238
264/278
238
266
238/266

317
311
315
311
317
315
311
317
313
315

Microsatellite markers are arranged according to their order along chr. 5 from centromere to telomere. Shaded boxes represent the extent of the duplications in different patients.
Numbers in each box represent alleles as fragment sizes in base pairs (bp). For some families we could not determine the phase at all loci. In these cases, both alleles are shown.

As described above, three of the duplications were shared by more
than one family (Fig. 1A, Table 1). In these cases, families with identical duplications had the same haplotype on the duplicated allele
suggesting that they arose from the same mutational event derived
from a common founder. In 10 of the 16 independent duplications,
we had two or more affected members and were able to phase the
alleles on the duplicated segment and compare haplotypes associated with the duplications. We did not observe haplotypes shared
among families with different duplication sizes suggesting that an
“at risk” chromosomal haplotype is unlikely (Table 2).

Expression Analysis of LMNB1 at mRNA and Protein Levels
To determine the relative contribution of the normal and duplicated LMNB1 alleles to gene expression, we set up a primer extension assay exploiting a polymorphism in the 3 -UTR of the lamin
B1 gene (rs#1051644): six patients (IT1, IT2, IT3, FR1, FR2, and
US1) were heterozygous and could be used in this assay. Based on
the calibration curve, all patients carrying a duplication showed a
genomic DNA ratio between the two alleles of the rs#1051644 SNP
of 65%–35%. A similar ratio was seen when the assay was carried
out on cDNA from patient fibroblasts and blood (Fig. 5A–C). This
indicated that the three lamin B1 gene copies in a duplication carrier
were equally expressed.
Real-time PCR on cDNA derived from fibroblasts or blood
showed an increase in LMNB1 expression ranging from 2.1 to 4.8
relative to the control samples, whereas expression was found to
range from 1.6 to 3.2-folds at the protein level (Fig. 5D–F). Expression levels in patients were significantly higher than controls
both at the RNA and protein levels. Variability in expression levels
was also noted among members of the same family (Fig. 5, subjects
IT3.1, 3.2, 3.3). This suggested that it was unlikely that expression in
patient samples was correlated with the size of the duplication and
that differences in expression maybe due to experimental variations
or differences in cell culture conditions.

Discussion
We studied a group of twenty ADLD families by high-resolution
aCGH to map the LMNB1 duplication boundaries. Two cases allowed us to define the minimum critical duplicated region required
for the development of ADLD which was ∼72 kb, and extended
from ∼9.9 kb upstream of the 5 -UTR, and ∼1.8 kb downstream of
the 3 -UTR of LMNB1 (Fig. 1A). LMNB1 is the only gene contained
in this region and no other gene is even partially duplicated. This
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confirms that the duplication of LMNB1 alone is sufficient to cause
ADLD.
Clinical features of ADLD patients were similar in all patients in
whom LMNB1 was the only gene completely duplicated, and we did
not notice differences associated with different duplication extents.
The only possible exception is patient BR1, in whom the initial
symptoms were not autonomic dysfunction. The BR1 duplication
was the only one that encompassed the complete coding regions of
other genes. This large inverted duplication involved three genes centromeric to LMNB1, namely GRAMD3, ALDH7A1 (MIM #107323),
PHAX (MIM #604924). This may suggest that the involvement of
one of these genes may play a role as modifier of the disease phenotype or that the clinical spectrum of ADLD, particularly concerning
the symptoms at onset, is wider than expected.
Genotyping microsatellite markers around the LMNB1 gene in
patients revealed two important characteristics regarding the ADLD
duplications: (1) subjects with identical junctions shared the same
haplotype, suggesting the presence of a common founder. It confirms that LMNB1 duplications are indeed nonrecurrent and that
identical duplications in different families derived from the same
mutational event; (2) the duplications were the result of intrachromosomal rearrangements. This is similar to MECP2 and PLP1 duplications that were also shown to arise from intrachromosomal
events [Bauters et al., 2008; Inoue et al., 1999].
Fifteen of the 16 duplications (94%) had a “simple” head to tail
tandem orientation as defined by the fact that there was only a single
duplication junction. One of these also showed a triplication (families A6, A7, K2–3). It is likely that the triplication arose subsequent
to the original LMNB1 duplication through an independent repeatmediated NAHR mechanism mediated by the flanking LIPA3 LINE
repeats. It thus represents a second duplication event on one of the
duplicated alleles and we have counted this event as a simple duplication. The only “complex” duplication was found in patient BR1, and
consisted of an inverted duplicated segment. Compared with other
diseases in which nonrecurrent duplications have been analyzed in
detail such as PMD, developmental delay caused by MECP2 duplications and Potocki-Lupski microduplication syndrome (PTLS), the
percentage of complex duplications in ADLD appears to be much
lower [Carvalho et al., 2009; Lee et al., 2007; Zhang et al., 2009a;
2009b]. It is unclear if this over representation of simple duplication
events is a characteristic of the mechanisms involved in the ADLD
duplications.
The identification, for the first time, of a large number of LMNB1
duplication junction sequences has allowed us to speculate on
the mechanisms that may underlie these genomic rearrangements.
Given that LCRs do not flank the LMNB1 gene and the duplications

Figure 5. Lamin B1 expression analysis. A: Calibration of the SNaPshot experiment using known concentrations of two plasmids containing
the C and T allele of SNP #rs1051644. Percentages indicate the C:T ratio. A reproducible correlation between expected (x-axis) and measured
(y-axis) values were obtained. On the right, electropherograms at different relative concentrations. B: Scheme of the wild-type heterozygous SNP
rs#1051644 and of the two possible duplication configurations. The table on the bottom shows the results of the SNaPshot experiments whose
graphic is in panel C (values = mean ± standard error). C: SNaPshot results of the rs#1051644 analysis on genomic DNA (gDNA) and cDNA
derived from fibroblasts of controls (ctrls) and patients (ADLD), showing the C:T ratio (y-axis). Controls are shown as black-filled circles (gDNA)
and empty circles (cDNA), patients are shown as black-filled squares (gDNA) and empty squares (cDNA). Heterozygous controls cluster around
50%, whereas duplication carriers cluster around 65% or 35% depending on which of the two alleles is duplicated (∗∗∗ P < 0.001; ∗∗ P < 0.01).
D: Real-time experiments measuring LMNB1 cDNA levels compared with the reference gene HMBS. Patients showed a statistically significant
increase compared with controls both on mRNA derived from fibroblasts and from blood (∗∗ P < 0.01). E: Western blot analysis shows increased
LMNB1 expression in patients compared with control samples (samples were normalized using the MemCode system); full Western blot images
and MemCode staining are available in Supp. Fig. S1). On the right, the OD quantification of LMNB1 compared with MemCode staining. In all
patients, LMNB1 protein levels were significantly increased compared with controls (∗∗ P < 0.01; ∗ P < 0.05).

are nonrecurrent, nonallelic homologous recombination (NAHR)
is an unlikely mechanism for the generation of most of the LMNB1
duplications, with the exception of the Alu–Alu-mediated rearrangements in patient A4 and the triplication in families A6, A7, K2–3.
Alu–Alu-mediated duplications have been reported throughout the
genome and Alu elements with identities as low as 76% have been
shown to mediate tandem duplications [O’Neil et al., 2007]. However, recent reports have also suggested that replication mechanism
such as FoSTeS/MMBIR can also explain Alu–Alu-mediated rearrangements [Vissers et al., 2009; Zhang et al., 2009a]. The lack of
LCRs around LMNB1 is also interesting. This is in contrast to other
well studied diseases caused by nonrecurrent duplications, such as
those involving the PLP1, MECP2 genes and PTLS, where LCRs are
thought to play an important role in duplication formation [Becker
et al., 2011; Carvalho et al., 2009; Lee et al., 2006; Woodward et al.,
2005; Zhang et al., 2009b].
Four of the 16 patients showed an insertion at the duplication
junctions ranging from four to 12 nucleotides. Insertions are usually
a hallmark of NHEJ mechanisms and represent “information scars”
at the repair sites of double stranded breaks (DSB) [Lieber, 2008;

McVey and Lee, 2008]. It is interesting that the centromeric breakpoints of these four patients clustered within 25 kb of each other, a
grouping that was statistically significant. This might indicate that
these duplications share a common mechanism mediated by the
genomic architecture surrounding their centromeric breakpoints.
The majority of the duplication junction sequences (11 of 16)
show the presence of an overlap of between 1 and 6 bp with 2 bp being the most frequently observed microhomology. Microhomology
at duplication and deletion junctions has been a defining feature
in numerous studies involving rearrangements associated with diseases such as PMD and MECP2 associated developmental delay
[Carvalho et al., 2009; Woodward et al., 2005]. It has been shown
that 75% of tandem duplications and 80% of deletions associated
with pathogenic CNVs contained regions of microhomolgy at their
junctions [Vissers et al., 2009]. The presence of microhomology
at rearrangements junctions is usually a signature of a nonhomologous repair process NHEJ or alternative NHEJ (also known as
microhomology-mediated end joining (MMEJ). These NHEJ mechanisms have been implicated in both normal copy number variations and duplications and deletions associated with such disease
HUMAN MUTATION, Vol. 34, No. 8, 1160–1171, 2013

1169

[Carvalho et al., 2009; Vissers et al., 2009; White and den Dunnen,
2006; Woodward et al., 2005].
The genomic rearrangement in BR1 is a complex duplication
difficult to explain using an NHEJ model, but compatible with
a replication fork switching mechanism such as FoSTeS/MMBIR.
Inverted Alu elements have been shown to predispose to replication fork stalling, double stranded breaks and inverted duplications
[Lobachev et al., 2002; Voineagu et al., 2008]. While these repeats
have been close enough to form cruciform structures, evidence has
suggested that inverted repeats, even at a distance, can lead to inversions [Carvalho et al., 2011]. We propose a model whereby the
presence of the inverted Alu element results in a replication blockage
that causes a template-switching event in the vicinity of I1. We propose that three template-switching events occurred to produce the
complex rearrangement (Fig. 3D): (1) the replication fork switches
to the opposite sister chromatid because of the homology of an inverted AluY-B element (first junction sequence I1–J1, Fig. 3). (2)
After progressing for a short distance (78 bp), the nascent strand
disengages and a microhomology-mediated migration to another
replication fork occurs. This is not mediated by an inverted repeat
and thus maintains the inverted orientation (second junction sequence J2–T2). (3) Replication progresses for ∼475 kb, resulting in
the duplication of the LMNB1, PHAX, ALDH7A1, and GRAMD3
genes, and finally a third template-switching event causes the migration of the replication fork back to the strand in the direct orientation, again mediated by a microhomology (third junction C2–I2).
This complex event results in the final configuration of the inverted
duplication observed in BR1.
An analysis of the genomic architecture surrounding the breakpoint junctions suggests a number of features that may predispose
the region to genomic instability leading to the LMNB1 duplication; the most striking of which is the involvement of Alu repetitive
elements at the duplication breakpoints. One of the duplications
also shows the presence of Alu elements at both ends. In addition,
they are also involved in the insertion junctions of the complex
BR1 duplication. The enrichment of Alu repetitive elements is most
striking around the centromeric duplication junctions and this increased frequency is likely a consequence of an enrichment of Alu
sequences in the centromeric part of the genomic region surrounding the LMNB1 gene. Alu repeat enrichment has been previously
reported for MECP2 duplication junctions and in the vicinity of
LCRs [Bailey et al., 2003; Bauters et al., 2008]. A higher Alu density
in the MSH2 gene was shown to be associated with an increased frequency of Alu-mediated deletions [Li et al., 2006]. Thus, although
there is a clear association between Alu elements and genomic rearrangements, the exact mechanisms are unclear. ADLD duplication junctions, in particular centromeric boundaries, also showed
a higher GC%. Alu-mediated deletions have been shown to occur
in regions with a high GC content (∼45%) [Sen et al., 2006] and
a high GC content was associated with early replicating regions as
well as an increased frequency of DNA breaks in neuroblastoma
translocations [Stallings, 2007].
We also noted an increased frequency of CTG/CAG trinucleotides
at the telomeric duplication breakpoints. Their enrichment was
originally found in E. coli, at junctions produced by gene amplification induced under stress conditions [Slack et al., 2006], and they
have also been found near MECP2 and PLP1 duplication breakpoints
[Carvalho et al., 2009]. It has been suggested that the CTG/CAG
motifs may represent a relationship between the ends of Okazaki
fragments and the involvement of the lagging strand in a long distance template-switching model [Slack et al., 2006]. It is interesting
that this motif is significantly enriched in the telomeric breakpoint
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sequences as these may represent sites of template switching between
the replication forks.
Which mechanism is likely to be responsible for the ADLD duplications? Given that the molecular signatures of both NHEJ/MMEJ
and replication-based mechanisms such as FoSTeS/MMBIR overlap,
it is difficult to answer that question definitively. It is also possible
that more than one mechanism is at play. However, several of lines
of evidence favor a replication-based FoSTeS/MMBIR mechanism.
Studies have shown that human fibroblast subjected to replication
stress can result in a high frequency of novel CNVs also characterized by short stretches (<6 bp) of microhomology at their junctions
thus suggesting a mitotic origin for CNV formation [Arlt et al.,
2012]. FoSTeS/MMBIR occurs during mitosis, whereas NHEJ appears to be downregulated during mammalian meiosis [Fiorenza
et al., 2001]. In addition to explaining simple tandem duplications
FoSTeS/MMBIR mechanisms can also more readily explain the presence of complex rearrangements and the incorporation of stretches
of DNA from multiple different genomic locations such as that
observed in the case of the BR1 duplication [Zhang et al., 2009a].
In patients’ fibroblasts, the expression analysis confirmed an increase of LMNB1 both at mRNA and protein levels. We demonstrated that the duplicated and normal LMNB1 alleles in ADLD
patients show equal expression, suggesting regulatory regions are
maintained within the rearranged segment. Given the presence of
three LMNB1 alleles, the theoretical increase of its expression is
1.5-fold. We demonstrated that the differences between expected
and observed values for LMNB1 expression are not due to the duplicated allele alone, because the three LMNB1 alleles were always
equally expressed. This may suggest that in case of duplication, the
LMNB1 mRNA/protein accumulates in patients’ cells. Such expression increments and the variability among patients were also found
for mRNA and protein levels in nerve biopsies from patients with
duplications of the PMP22 gene. Its origin was unknown, and it did
not correlate with disease severity [Katona et al., 2009].
In conclusion, we have carried out an analysis of the largest collection of ADLD families caused by LMNB1 duplications, to date. We
have been able to identify and analyze all the duplication junctions
at the base pair level. In contrast to previous reports, we show that
LMNB1 duplications can have a heterogeneous architecture with the
first description of an inversion involving LMNB1. We propose that
the genomic architecture, including the enrichment of Alu repetitive elements and higher GC%, especially in the genomic region
centromeric to the LMNB1 gene may play an important role in mediating the ADLD duplications. Given the overlapping signatures
of the different duplication generating mechanisms it is difficult to
identify unambiguously which of these is functioning in ADLD. It
is also possible that there may be more that one mechanism at play.
Our results suggest that NHEJ/MMEJ and replication-based mechanisms such as FoSTeS are likely to play an important role in the
formation of the duplications that cause ADLD.
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